Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Volume VI No. 2 - February 1, 1999

“Value Added” Services Essential to Success

ONE ELEMENT COMMON TO SUCCESSFUL LABORATORY ORGANIZATIONS of the future will be the ability to both understand the concept of “value added” services and to offer such services to customers. At its core, value added is an essential business strategy. There are many ways to define “value added.” But the intent is unquestioned. Any product …

“Value Added” Services Essential to Success Read More »

To access this post, you must purchase The Dark Report.

IMPATH Creates Its Brand Of Value-Added Pathology

CEO SUMMARY: IMPATH Inc. is a pathology company with an interesting twist. It doesn’t compete directly with community hospital-based pathologists like some national AP providers. Instead, it offers AP services which supplement the capabilities of the local pathologist. The formula must work. During IMPATH’s short life, it has grown rapidly. Revenues are up, profits are …

IMPATH Creates Its Brand Of Value-Added Pathology Read More »

To access this post, you must purchase The Dark Report.

IMPATH Points Pathology Toward a Winning Future

CEO SUMMARY: Pathology is about to undergo a market transformation similar to radiology. As clinicians insist on more precise diagnostic and prognostic information about their patients, pathologists will have a perfect opportunity to reposition themselves as essential partners with the referring physician. IMPATH points the way, but there is room for many other pathologists to …

IMPATH Points Pathology Toward a Winning Future Read More »

To access this post, you must purchase The Dark Report.

Beckman Coulter Gets New CEO, Stock Gets Analyst Downgrade

AFTER SPENDING MOST OF 1998 digesting its 1997 acquisition of Coulter Corporation, Beckman Coulter, Inc. is ready for new business initiatives in the diagnostics marketplace. Beckman Coulter enters 1999 with a new leader. John P. Wareham, currently President and CEO, will assume the additional duties of Chairman. Louis T. Rosso, Beckman’s long-time chief executive, stepped …

Beckman Coulter Gets New CEO, Stock Gets Analyst Downgrade Read More »

To access this post, you must purchase The Dark Report.

Lab Leads Hospital In Successful Effort To Reduce Infections

CEO SUMMARY: Most laboratorians struggle to get clinicians to pay close attention to the potential for lab data to improve healthcare outcomes. At Northwestern Memorial Hospital, the laboratory acqired in-house molecular typing test capability as one cornerstone for an aggressive infection control program. Physicians, nurses, med techs, pharmacists and even maintenance staff now regularly participate …

Lab Leads Hospital In Successful Effort To Reduce Infections Read More »

To access this post, you must purchase The Dark Report.

Top-Performing Labs at Executive War College

CEO SUMMARY: Once again, Executive War College time approaches. Scheduled for May 11-12, 1999 at the New Orleans Sheraton, this year’s roster of innovative laboratories promises to provide valuable insight about winning strategies. An expanded program offers a lab industry first: a knowledge track exclusively focused on the sales and marketing of laboratory and pathology …

Top-Performing Labs at Executive War College Read More »

To access this post, you must purchase The Dark Report.

HMO Membership Shows First-Ever Decline in 1998

CEO SUMMARY: One of the most closely-tracked surveys of health cost trends was released last week. William H. Mercer Inc.’s report revealed two significant facts. One, enrollment growth in HMO/POS plans actually declined for the first time. Two, costs rose at the fastest rate in five years. Each fact may be early warning to laboratory …

HMO Membership Shows First-Ever Decline in 1998 Read More »

To access this post, you must purchase The Dark Report.

“February 1, 1999 Intelligence: Late Breaking Lab News”

Are the financial fortunes of the national laboratories about to take a turn for the better? Financial analysts at FMR Corp. must think so. Last month the company disclosed that it had purchased 3 million common shares in Quest Diagnostics Incorporated, giving it a 10.3% ownership stake in the laboratory firm. FMR is the parent …

“February 1, 1999 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

;